









Mercado
/
Acciones
/
nasdaq-tech
/

Bio-Techne Corp

TECH

51.850USD

+1.370+2.71%

Cierre 09/26, 16:00（ET）Cotizaciones retrasadas 15 min

8.04BCap. mercado

109.53P/E TTM



Bio-Techne Corp

51.850

+1.370+2.71%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Compañía

Información de la empresa

Símbolo de cotizaciónTECH

Nombre de la empresaBio-Techne Corp

Fecha de salida a bolsaFeb 09, 1989

Director ejecutivoMr. Kim Kelderman

Número de empleados3100

Tipo de seguridadOrdinary Share

Fin del año fiscalFeb 09

Dirección614 Mckinley Pl N E

CiudadMINNEAPOLIS

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal55413

Teléfono16123792956

Sitio Webhttps://www.bio-techne.com/

Símbolo de cotizaciónTECH

Fecha de salida a bolsaFeb 09, 1989

Director ejecutivoMr. Kim Kelderman

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. John L. Higgins

Independent Director

65.24K

Mr. Kim Kelderman

President, Chief Executive Officer, Director

50.97K

+3.02%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

44.86K

Dr. Roeland Nusse, Ph.D.

Independent Director

44.56K

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

13.77K

Dr. Rupert J. Vessey, Ph.D.

Independent Director

9.35K

Ms. Julie L. Bushman

Independent Director

7.13K

Dr. Matthew F. Mcmanus

President - Diagnostics and Spatial Biology

4.74K

+169.49%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

4.38K

Dr. Judith V. Klimovsky, M.D.

Independent Director

2.14K

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. John L. Higgins

Independent Director

65.24K

Mr. Kim Kelderman

President, Chief Executive Officer, Director

50.97K

+3.02%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

44.86K

Dr. Roeland Nusse, Ph.D.

Independent Director

44.56K

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

13.77K

Dr. Rupert J. Vessey, Ph.D.

Independent Director

9.35K

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Consumables

257.79M

81.53%

Service

27.25M

8.62%

Instruments

26.11M

8.26%

Royalty

5.04M

1.59%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

181.92M

57.54%

EMEA, excluding U.K

66.50M

21.03%

Greater China

24.48M

7.74%

APAC, excluding Greater China

21.25M

6.72%

United Kingdom

12.85M

4.06%

Rest of World

9.18M

2.90%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Consumables

257.79M

81.53%

Service

27.25M

8.62%

Instruments

26.11M

8.26%

Royalty

5.04M

1.59%

Estadísticas de accionistas

Actualizado: mar., 19 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

5.65%

T. Rowe Price Associates, Inc.

5.53%

State Street Global Advisors (US)

3.76%

Atlanta Capital Management Company, L.L.C.

2.76%

Otro

70.48%

Accionistas

Proporción

The Vanguard Group, Inc.

11.82%

BlackRock Institutional Trust Company, N.A.

5.65%

T. Rowe Price Associates, Inc.

5.53%

State Street Global Advisors (US)

3.76%

Atlanta Capital Management Company, L.L.C.

2.76%

Otro

70.48%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

57.35%

Investment Advisor/Hedge Fund

30.62%

Hedge Fund

7.35%

Research Firm

2.52%

Bank and Trust

2.13%

Pension Fund

1.80%

Sovereign Wealth Fund

1.24%

Individual Investor

0.26%

Insurance Company

0.24%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

2023Q3

1217

156.41M

98.84%

-7.93M

2023Q2

1213

155.36M

98.68%

-4.04M

2023Q1

1206

153.08M

97.33%

-5.18M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

18.46M

11.77%

-66.38K

-0.36%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

9.31M

5.94%

+50.72K

+0.55%

Mar 31, 2025

T. Rowe Price Associates, Inc.

11.14M

7.11%

+717.26K

+6.88%

Mar 31, 2025

State Street Global Advisors (US)

6.53M

4.17%

+57.21K

+0.88%

Mar 31, 2025

Atlanta Capital Management Company, L.L.C.

3.72M

2.37%

+771.93K

+26.18%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.09M

2.61%

+92.10K

+2.30%

Mar 31, 2025

Invesco Capital Management LLC

2.96M

1.89%

+483.60K

+19.50%

Mar 31, 2025

Select Equity Group, L.P.

5.37M

3.42%

+3.03M

+129.77%

Mar 31, 2025

Mairs and Power, Inc.

2.80M

1.78%

-23.04K

-0.82%

Mar 31, 2025

Baron Capital Management, Inc.

3.28M

2.09%

-861.18K

-20.82%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

Vanguard ESG U.S. Stock ETF

Harbor Health Care ETF

Innovator Gradient Tactical Rotation Strategy ETF

Global X S&P 500 Risk Managed Income ETF

Global X Genomics & Biotechnology ETF

Calvert US Large-Cap Diversity, Eqty & Inc Idx ETF

Invesco NASDAQ Next Gen 100 ETF

iShares US Industry Rotation Active ETF

First Trust NASDAQ BuyWrite Income ETF

CCM Global Equity ETF

Vanguard ESG U.S. Stock ETF

Proporción0%

Harbor Health Care ETF

Proporción0%

Innovator Gradient Tactical Rotation Strategy ETF

Proporción0%

Global X S&P 500 Risk Managed Income ETF

Proporción0%

Global X Genomics & Biotechnology ETF

Proporción0%

Calvert US Large-Cap Diversity, Eqty & Inc Idx ETF

Proporción0%

Invesco NASDAQ Next Gen 100 ETF

Proporción0%

iShares US Industry Rotation Active ETF

Proporción0%

First Trust NASDAQ BuyWrite Income ETF

Proporción0%

CCM Global Equity ETF

Proporción0%

Dividendos

Un total de 250.90M USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Feb 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Oct 31, 2023

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023

Nov 10, 2023

Nov 24, 2023

Nov 09, 2023

Aug 08, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 01, 2023

Aug 17, 2023

May 03, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 26, 2023 going ex on May 12, 2023

May 15, 2023

May 26, 2023

May 12, 2023

Feb 02, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Feb 27, 2023 going ex on Feb 10, 2023

Feb 13, 2023

Feb 27, 2023

Feb 10, 2023

Nov 01, 2022

TECH.NB Final Cash Dividend of gross USD 0.32 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

División de acciones

Fecha

Tipo

Relación

Nov 01, 2022

Split

1→4

Fecha

Tipo

Relación

Nov 01, 2022

Split

1→4

KeyAI

